A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the effect of food upon the pharmacokinetics
(PK) of SEN0014196 in subjects with Huntington disease (HD).